* Note: Prices are in Million (M) USD.
Description:
Aurora Cannabis Inc. (ACB) is a prominent leader in the global medical cannabis industry, headquartered in Edmonton, Canada. The company boasts a diverse portfolio of innovative brands and offers an extensive range of high-quality cannabis products tailored to meet the evolving needs of patients worldwide. Committed to advancing the sector through rigorous research and development, Aurora leverages its expertise to navigate a competitive landscape and position itself as a trusted provider of medical solutions. As the cannabis market continues to expand, Aurora is strategically poised to capitalize on emerging opportunities while reinforcing its role as a pioneer within the industry.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $140 M
Debt : $60 M
EBITDA : $51 M
Since Cash is greater than Total Debt, 5 points assigned.
This criteria used industry in which company operates:
Sector: Healthcare
Industry: Drug manufacturers - specialty & generic
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 45.81
Since Forward PE Ratio is greater than 35, 0 point assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Using last 19 overlapping fiscal years (max 20).Average Free Cash Flow: $-116 M
Average Revenue: $100 M
Revenue Converted To Free Cash Flow (%): -115.7%
Since Free Cash Flow (FCF) to Revenue percentage is non-positive, 0 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2025-03-31): $343 M
Revenue 5 Years Ago (2020-03-31): $269 M
Total Growth over 5 Years: 27.8%
5-Year Revenue CAGR (Historical): 5.0%
Forward 5-Year CAGR (Tapered): 4.5%
Since historical Revenue CAGR is between 5 - 10, 2 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2025-03-31): $56 M
Share Count 5 Years Ago (2021-03-31): $17 M
Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $0.11
Trailing 12-Month Earnings Per Share (EPS): $0.00
Average Earnings Per Share (EPS): $0.11
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0.00%
Since Dividend Per Share is less than or equal to 0, 0 point assigned.
Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Using last 19 valid ROE years (max 20).Average ROE: -54.0%
Since Average ROE is non-positive, 0 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $4.81
52-Week Low: $3.42
Threshold Price (15% Above 52-Week Low): $3.94
Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $295 M
Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based on the market cap, we recommend do not exceed 0.5% exposure of Total Portfolio.
Warren Buffett's Owners' Earnings:
No positive free cash flow found (TTM or annual) to compute Owners' Earnings per share.
Note: Many fast-growing companies reinvest heavily, so Owners' Earnings may appear low.
Consider other factors in your valuation.
Value-Trade has assigned 11 points to above Aurora Cannabis Inc (ACB) stock.
Fair Value PE
12, Industry Based PE
15, Growth Based PE
15, Risk-Free Anchored PE (25% MoS)
18.2. Based on these 4 values, average assigned is
15.05. Value-Trades has assined P/E value
15.05. An average (Current Year EPS + Next Year EPS) earning per share is
$0.105.
Fair value using multiple P/Es (blended): $1.58 (PE 15.05 × EPS $0.11)
So the Final Fair Value is: $1.58
Understanding the Value-Trades P/E Blend (click to expand)
▾
What goes into the blended P/E?
- 20-Year Avg P/E — Long-run market baseline; conservative anchor.
- Fair Value P/E — Score-based (cash, debt, sector, etc.).
- Industry P/E — Peer group norm.
- Growth-Based P/E — Uses tapered growth rates, floored at 15.
- RCFC-Based P/E — Maps cash conversion efficiency.
- ROE-Based P/E — Higher ROE supports higher multiples.
- Risk-Free Anchored P/E — Macro floor tied to 10y yield w/ MoS.
How it works
- Extreme values are clamped/filtered (IQR method).
- Anchors (20y avg, RCFC/ROE, risk-free) are always kept if valid.
- Final fair value = min(Blended PE × EPS, Avg PE × EPS).
P/E Reference Summary
Using EPS: $0.11
| Source |
P/E Ratio |
Implied Fair Value |
| Market (1 Yr Ago) | 236.7 | $24.85 |
| Value-Trades Assigned | 15.05 | $1.58 |
